C. Katlama

Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients

A. d’Arminio Monforte, C. Fagard, F. Bai, 2010, AIDS.

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

R. Landman, G. Collin, A. Storto, 2010, Antimicrobial Agents and Chemotherapy.

A truncated HIV Tat demonstrates potent and specific latency reversal activity

B. Autran, D. Margolis, N. Archin, 2023, bioRxiv.

Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals

R. Tubiana, C. Katlama, O. Godin, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.